跳至主要内容
临床试验/CTRI/2020/05/025191
CTRI/2020/05/025191尚未招募未知

Pre and post treatment total Serum Ig E levels amongpatients of Dermatophytosis and itâ??s correlation withclinical, mycological cure rate and relapse rate.

GCS Medical College Hospital and Research Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Patients of either sex age between 18 to 60 years.
  • 2)Presence fungus in scrapping taken from lesion by in KOH preparation.
  • 3)Women of child bearing age must have a negative urine pregnancy test.
  • 4)Patient willing to give written informed consent for study Exclusion criteria.

排除标准

  • 1)Patient less than 18 years age and more than 60 years.
  • 2)Pre-existing Cardiovascular, pulmonary, hepatic, renal, haematological, gastrointestinal, endocrine, immunologic, musculoskeletal, neurological or psychiatric disease.
  • 3)Major surgical or medical illness in last 4 weeks before screening.
  • 4)Any concomitant medication for purpose other than dermatophytosis management at presentation or within last 4 weeks before screening.
  • 5)Any concomitant intake of herbal, homeopathic or other alternative therapy at presentation or within last 4 weeks before screening.
  • 6)Alcohol dependence, alcohol abuse or drug abuse within past one year.
  • 7)Moderate to heavy smoking ( >10 cigarettes/day) or consumption of tobacco products
  • 8)Clinically significant illness within 4 weeks before the start of the study
  • 9)Asthma, urticaria or other allergic type reactions after taking any medication
  • 10)Past History of atopy, Family history of atopy in first degree relatives.
  • 11)Pregnant and lactating women
  • 12)Patient having pre-existing medical condition (DM HT or any other medical condition requiring concomitant medicine.) or diagnosed during screening.
  • 13)Clinically diagnosed as dermatophytic skin infection but negative for fungus in KOH examination.
  • 14)Dermatophytosis independently or concomitantly involving scalp (T. Capitis), nail (onychomycosis), palm (T. pedis) and sole (T. mannum).
  • 15)Patients having skin lesions with secondary bacterial infections.
  • 16)Past or present history of atopy including any type of eczema, H/o contact sensitization, Allergic rhinitis or Asthma.
  • 17)HIV Hepatitis B, C positive patients.

研究者

发起方
GCS Medical College Hospital and Research Centre

相似试验